Adamis pharmaceuticals corp (ADMP)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10
REVENUE, net

21,871

22,113

20,727

18,657

16,813

15,086

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

0

-

-

0

0

0

0

0

0

REVENUE, net

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

REVENUE, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

COST OF GOODS SOLD

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

COST OF GOODS SOLD

15,540

15,478

14,319

12,631

11,360

9,797

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Gross Profit

6,330

6,635

6,407

6,026

5,452

5,288

5,234

4,998

5,396

5,653

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

23,320

25,287

26,898

28,133

27,495

25,948

25,215

24,428

23,720

22,819

21,568

21,155

20,083

17,127

14,361

11,151

8,830

9,007

9,382

8,601

7,349

5,891

4,466

3,884

3,389

2,601

2,367

2,034

2,008

1,813

2,078

2,555

2,649

2,648

2,769

2,958

3,365

0

0

0

RESEARCH AND DEVELOPMENT

10,216

10,375

16,161

16,751

18,741

18,793

14,575

11,915

8,265

7,526

5,315

5,562

7,806

9,697

9,360

9,048

6,888

4,843

5,015

4,430

4,900

3,924

2,924

2,522

1,006

973

971

1,197

1,209

1,643

1,618

1,771

2,165

2,152

4,063

3,506

2,875

0

0

0

IMPAIRMENT EXPENSE

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

LOSS ON IMPAIRMENT OF FIXED ASSETS

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from Operations

-30,671

-29,350

-36,966

-38,868

-40,794

-39,463

-34,556

-31,441

-26,686

-24,789

-21,603

-22,382

-24,896

-25,204

-22,885

-19,618

-15,718

-13,850

-14,397

-13,031

-12,250

-9,816

-7,390

-6,406

-4,395

-3,575

-3,338

-3,232

-3,217

-3,456

-3,697

-4,327

-4,815

-4,800

-6,832

-6,464

-6,241

0

0

0

OTHER INCOME (EXPENSE)
Interest Expense

137

123

93

102

131

157

184

206

214

231

0

0

0

-

0

0

-

-

-

-

-

371

5,669

8,447

8,626

9,095

4,642

2,443

2,333

1,722

879

302

35

64

133

449

744

0

0

0

Interest Income

124

175

257

293

280

245

179

153

137

102

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inducement Expense for Exercise of Warrants

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on Extinguishment of Debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in Fair Value of Warrant Liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,049

-343

-483

1,040

-433

-120

645

-38

926

676

-1,353

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

Gain on Sale of Asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Change in Fair Value of Warrant Derivative Liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

348

279

299

-79

-155

31

455

-19

46

0

0

0

-

0

-

-

-

-

-

-

-

0

0

-

-

-

-

Gain on Sale of Asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

Change in Fair Value of Derivative Liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

919

908

-249

-111

-122

0

0

0

-

-

-

-

-

-

-

-

Change in Fair Value of Conversion Feature Liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,985

3,015

2,270

406

-1,390

0

0

0

-

-

-

-

-

-

-

-

Change in Fair Value of Warrants Liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

Change in Fair Value of Derivative Liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Change in Fair Value of Conversion Feature Liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Change in Fair Value of Conversion Feature Liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Total Other Income (Expense), net

-13

52

163

190

149

87

-4

-1,013

-1,037

-1,089

-1,154

-250

1,520

1,192

481

709

-1,120

278

152

-190

-207

-1,052

-4,696

-3,588

-3,760

-4,535

-1,216

-2,148

-3,847

-3,236

-2,013

-2,004

-30

0

0

0

-

-

-

-

Net (Loss)

-30,692

-29,306

-36,433

-38,308

-40,275

-39,006

-34,221

-32,115

-27,384

-25,538

-18,183

-18,058

-18,801

-19,437

-22,404

-18,908

-16,838

-13,571

-14,245

-13,221

-12,458

-10,868

-12,087

-9,994

-8,155

-8,240

-4,685

-5,510

-7,194

-6,763

-5,781

-6,401

-4,915

-6,802

0

0

-

0

-

-

Deemed Dividend on Preferred Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (Loss) Applicable to Common Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Basic and Diluted (Loss) Per Share
Basic and Diluted (Loss) Per Share (in dollars per share)

-0.15

-0.08

-0.12

-0.16

-0.19

-0.27

-0.21

-0.29

-0.23

-0.24

-0.21

-0.19

-0.26

0.07

-0.41

-0.37

-0.48

-

-

-

-

-

-

-

-

-0.82

0.00

-0.17

-

-0.34

-0.01

-0.03

-0.01

-0.01

-0.02

-0.02

0.02

-0.04

-0.05

-0.04

Basic and Diluted Weighted Average Shares Outstanding (in shares)

66,499

61,921

56,283

47,539

47,311

47,477

42,085

33,389

33,389

33,549

31,509

26,221

22,118

21,579

19,606

15,373

13,444

-

-

-

-

-

-

-

-

6,741

6,169

6,144

-

5,810

98,293

97,206

94,021

91,885

89,698

82,305

123,721

70,005

31,614

29,804

Basic (Loss) Per Share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.28

-0.23

-0.27

-0.24

-0.42

-0.20

-0.27

-0.15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic Weighted Average Shares Outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,438

13,420

13,415

12,828

10,564

10,514

10,500

10,384

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (Loss) Per Share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.20

-0.24

-0.27

-0.32

-0.42

-0.20

-0.27

-0.16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted Weighted Average Shares Outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,740

13,504

13,415

13,086

10,564

10,514

10,500

10,447

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-